AWKNF 0.20 Awakn Life Sciences Corp.
| Range: | 0.0422-0.26 | Vol Avg: | 10680 | Last Div: | 0 | Changes: | -0.01 |
| Beta: | 2.65 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Aug 03 2021 | Empoloyees: | 6 | ||
| CUSIP: | CIK: | ISIN: | CA05455W1086 | Country: | CA | ||
| CEO: | Mr. Anthony Tennyson | Website: | https://awaknlifesciences.com | ||||
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow